Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia
Top Cited Papers
Open Access
- 1 June 2007
- Vol. 129 (5) , 879-890
- https://doi.org/10.1016/j.cell.2007.03.043
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemiaBlood, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- TWIST2 Demonstrates Differential Methylation in Immunoglobulin Variable Heavy Chain Mutated and Unmutated Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2005
- Cancer as a Complex Phenotype: Pattern of Cancer Distribution within and beyond the Nuclear FamilyPLoS Medicine, 2004
- A NotI–EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignanciesGenomics, 2004
- Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin LymphomaThe Journal of Experimental Medicine, 2003
- Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription FactorScience, 2002
- TGF-β induces apoptosis through Smad-mediated expression of DAP-kinaseNature Cell Biology, 2001
- DAP-kinase Participates in TNF-alpha and Fas-induced Apoptosis and Its Function Requires the Death DomainThe Journal of cell biology, 1999
- Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer ProbandsJNCI Journal of the National Cancer Institute, 1994